chlorprothixene has been researched along with Parkinson Disease, Secondary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Merlis, S; Sheppard, C | 1 |
| Gabriel, E; Karobath, M; Lenz, G | 1 |
1 trial(s) available for chlorprothixene and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Effect of different neuroleptics in tardive dyskinesia and parkinsonism. A video-controlled multicenter study with chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden. Nordic Dyskinesia Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Biperiden; Chlorprothixene; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Perphenazine; Psychiatric Status Rating Scales; Psychotic Disorders; Random Allocation | 1986 |
2 other study(ies) available for chlorprothixene and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Drug-induced extrapyramidal symptoms: their incidence and treatment.
Topics: Chlorpromazine; Chlorprothixene; Extrapyramidal Tracts; Female; Fluphenazine; Humans; Male; Parasympatholytics; Parkinson Disease; Parkinson Disease, Secondary; Perphenazine; Phenothiazines; Prochlorperazine; Thioridazine; Tranquilizing Agents; Trifluoperazine | 1967 |
[The extrapyramidal symptoms in the combination of lithium long-term lithium therapy with nortriptyline. A case report on the formation of a pathogenesis hypothesis].
Topics: Adult; Basal Ganglia Diseases; Bipolar Disorder; Chlorprothixene; Clopenthixol; Dibenzazepines; Drug Synergism; Drug Therapy, Combination; Female; Humans; Lithium; Long-Term Care; Nortriptyline; Parkinson Disease; Parkinson Disease, Secondary; Procyclidine; Propranolol; Synapses; Thioridazine | 1976 |